Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer

NCT03684733 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT03684733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03684733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
March 13, 2017
Completion date
November 15, 2019
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, brca2 mutation, mammography, mri